Focus – Opinions and Features

The AlzPI and PCOM Symposium is an annual interdisciplinary event focused on exploring the role of infections and the microbiome in chronic neurological and psychiatric diseases, including Alzheimer’s, Parkinson’s, Lyme disease, long COVID, and more. It brings together... Read More »

By Fred Diamond When Lauren Lovejoy, founder of Lyme Warrior, joined me on the Love, Hope, Lyme podcast this week, she shared a story that captures both the heartbreak and resilience at the core of the Lyme disease community. Twelve years ago, she was in her mid-20s and was... Read More »

By Edward Dabdoub Lyme disease can cause serious and lasting impairments that make it impossible to work full-time. Yet, because symptoms of Lyme disease are typically subjective, or self-reported, insurance companies tend to question the legitimacy of Lyme-related claims.... Read More »

By Fred Diamond Unfortunately, people suffering from the mysterious, lingering symptoms of Lyme disease have probably heard a familiar refrain from their medical practitioners: “You can’t have Lyme disease. We don’t have Lyme here.” The here could be North Carolina, Texas,... Read More »

Meghan Bradshaw gave the following speech at a recent fundraising dinner held by the International Lyme and Associated Diseases Educational Foundation. ILADEF is the educational arm of ILADS, focused on training physicians in the diagnosis and treatment of Lyme and other... Read More »

This is Part Two of a series on Supportive Oligonucleotide Therapy (SOT),  a form of antisense oligonucleotide therapy. SOT is a personalized, gene-silencing treatment designed to disrupt pathogens like Lyme disease. Read Part One here. By Maria Marian, ND, MSE The idea of... Read More »

By Fred Diamond In this week’s episode of the Love, Hope, Lyme podcast, Athena Brownson, a former professional skier turned Denver real estate agent and Lyme advocate, spoke about her remarkable transformation from a sick person to one who has thrived. Once defined by athletic... Read More »

Part One of a two-part series. By Maria Marian, ND, MSE For many people facing chronic infections such as Lyme disease, Epstein–Barr virus (EBV), herpes simplex virus (HSV-1 and HSV-2), or cytomegalovirus (CMV), the journey can be long and frustrating. Antibiotics, antivirals,... Read More »

By Fred Diamond Lyme awareness got a major boost recently with the publication of the new National Academies of Sciences, Engineering, and Medicine (NASEM) report “Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses.” Lyme survivors, their... Read More »